Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds

Core Insights - Eli Lilly's GLP-1 weight-loss drug has shown potential in temporarily suppressing food-craving signals in patients with severe binge-eating issues [1] Group 1 - Researchers have been monitoring brain activity in a patient with severe binge-eating problems [1] - The findings suggest that the drug may have a significant impact on reducing food cravings [1]